Objectives Early and accurate diagnosis of lung cancer is crucial for effective treatment. This
study aimed to identify plasma microRNAs for diagnosis of lung cancer and for further …

Background Detection of lung cancer at an early stage by sensitive screening tests could be
an important strategy to improving prognosis. Our objective was to identify a panel of …

Results We identified 7 microRNAs separating lung cancer patients from controls. By using
RT-qPCR, we validated 6 microRNAs (miR-429, miR-205, miR-200b, miR-203, miR-125b …

The detection of nonsmall cell lung cancer (NSCLC) at an early stage presents a daunting
challenge due to the lack of a specific noninvasive marker. The discovery of microRNAs …

Background Lung cancer is the major cause of cancer death globally, it is often diagnosed at
an advanced stage and has one of the lowest survival rates of any type of cancer. The …

Rationale: Effective treatment for lung cancer requires accuracy in subclassification of
carcinoma subtypes. Objectives: To identify microRNAs in bronchial brushing specimens for …

The association of lung cancer with changes in microRNAs in plasma shown in multiple
studies suggests a utility for circulating microRNA biomarkers in non-invasive detection of …

Introduction: Since currently no sensitive and specific biomarkers for early detection of lung
adenocarcinoma (AD) exist and the majority of AD patients are diagnosed at late stages of …

Lung cancer is the leading cause of cancer death in men and women worldwide. The lack of
specific and sensitive tools for early diagnosis as well as still-inadequate targeted therapies …

Introduction The objective of the study was to develop a panel of microRNAs (miRNAs) as
highly sensitive and specific biomarkers for lung cancer early detection. Materials and …